Tuberculosis and Respiratory Diseases

The Korean Academy of Tuberculosis and Respiratory Diseases (대한결핵및호흡기학회)
권호 표지

Diagnosis and Treatment of Pulmonary Tuberculosis

폐결핵의 진단과 치료

  • Koh, Won-Jung (Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine Seoul) ;
  • Kwon, O Jung (Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine Seoul)
  • 고원중 (성균관대학교 의과대학 내과학교실, 삼성서울병원 호흡기내과) ;
  • 권오정 (성균관대학교 의과대학 내과학교실, 삼성서울병원 호흡기내과)
  • Published : 2005.05.30
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Korean Academy of Tuberculosis and Respiratory Diseases. Guideline of management of pulmonary tuberculosis. Tuber Respir Dis 1997;44:1447-53
  2. Korean Center for Disease Control and Prevention. Guidelines for the control of tuberculosis 2005. Seoul;2005
  3. World Health Organization. Treatment of tuberculosis:guidelines for national programmes. 3rd ed. Geneva:World Health Organization; 2003
  4. Centers for Disease Control and Prevention. Update:nucleic acid amplification tests for tuberculosis. MMWR Morb Mortal Wkly Rep 2000;49:593-4
  5. American Thoracic Society. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 2000;161:1376-95 https://doi.org/10.1164/ajrccm.161.4.16141
  6. Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Friedman LN, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America:treatment of tuberculosis. Am J Respir Crit Care Med 2003;167:603-62 https://doi.org/10.1164/rccm.167.4.603
  7. British Thoracic Society. Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Thorax 1998;53:536-48 https://doi.org/10.1136/thx.53.7.536
  8. Migliori GB, Raviglione MC, Schaberg T, Davies PD, Zellweger JP, Grzemska M, et al. Tuberculosis management in Europe. Eur Respir J 1999;14:978-9
  9. Kim SJ. Laboratory diagnosis of tuberculosis. In:Hong YP, Kim SJ, editors. Tuberculosis. 4th ed. Seoul: Korean National Tuberculosis Association and Korean Academy of Tuberculosis and Respiratory Diseases; 1993. p. 96-117
  10. American Thoracic Society. Rapid diagnostic tests for tuberculosis: what is the appropriate use? Am J Respir Crit Care Med 1997;155:1804-14 https://doi.org/10.1164/ajrccm.155.5.9154896
  11. Jeon K, Koh WJ, Kwon OJ, Suh GY, Chung MP, Kim H, et al. Recovery rate of nontuberculous mycobacteria from acid-fast bacilli smear-positive sputum specimens at a medical center in South Korea. Int J Tuberc Lung Dis 2005. In press
  12. Yu CM, Koh WJ, Ryu YJ, Jeon K, Choi JC, Kang EH, et al. Usefulness of PCR test for M. tuberculosis for the differentiation of pulmonary tuberculosis and nontuberculous mycobacterial lung disease in patients with smear-positive sputum. Tuber Respir Dis 2004;57:528-34 https://doi.org/10.4046/trd.2004.57.6.528
  13. Korean National Institute of Health & Korean Institute of Tuberculosis. Annual report on the notified tuberculosis patients in Korea 2003. Seoul;2004
  14. Centers for Disease Control and Prevention. Nucleic acid amplification tests for tuberculosis. MMWR Morb Mortal Wkly Rep 1996;45:950-2
  15. Espinal MA, Laszlo A, Simonsen L, Boulahbal F, Kim SJ, Reniero A, et al. Global trends in resistance to antituberculosis drugs. N Engl J Med 2001;344:1294-303 https://doi.org/10.1056/NEJM200104263441706
  16. Kim JH, Kim JH, Jang TW, Jung MH. Drug-resistant pulmonary tuberculosis in Kosin Medical Center. Tuber Respir Dis 1995;42:831-7 https://doi.org/10.4046/trd.1995.42.6.831
  17. Kim SY, Jeong SS, Kim KW, Shin KS, Park SG, Kim AK, et al. Drug-resistant pulmonary tuberculosis in a tertiary referral hospital in Korea. Korean J Intern Med 1999;14:27-31
  18. Lee JH, Chang JH. Drug-resistant tuberculosis in a tertiary referral teaching hospital of Korea. Korean J Intern Med 2001;16:173-9 https://doi.org/10.3904/kjim.2001.16.3.173
  19. Espinal MA, Kim SJ, Suarez PG, Kam KM, Khomenko AG, Migliori GB, et al. Standard shortcourse chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. JAMA 2000;283:2537-45 https://doi.org/10.1001/jama.283.19.2537
  20. Migliori GB, Espinal M, Danilova ID, Punga VV, Grzemska M, Raviglione MC. Frequency of recurrence among MDR-TB cases 'successfully' treated with standardised short-course chemotherapy. Int J Tuberc Lung Dis 2002;6:858-64
  21. Seung KJ, Bai GH, Kim SJ, Lew WJ, Park SK, Kim JY. The treatment of tuberculosis in South Korea. Int J Tuberc Lung Dis 2003;7:912-9
  22. Lee HS, Song HS, Lee HK, Kim KH, Chung HS, Kim CK, et al. Isoniazid metabolisms and its clinical implications in Koreans. Tuber Respir Dis 1962;12:22-37
  23. Shim TS, Koh WJ, Yim JJ, Lew WJ. Diagnosis and treatment of latent tuberculosis infection. Tuber Respir Dis 2004;57:101-8 https://doi.org/10.4046/trd.2004.57.2.101
  24. Ahn SJ, Park SJ, Kang KW, Suh GY, Chung MP, Kim H, et al. Pharmacokinetic profiles of isoniazid and rifampin in Korean tuberculosis patients. Tuber Respir Dis 1999;47:442-50 https://doi.org/10.4046/trd.1999.47.4.442
  25. British Thoracic Society. A controlled trial of 6 months' chemotherapy in pulmonary tuberculosis: final report: results during the 36 months after the end of chemotherapy and beyond. Br J Dis Chest 1984;78:330-6 https://doi.org/10.1016/0007-0971(84)90165-7
  26. Combs DL, O'Brien RJ, Geiter LJ. USPHS Tuberculosis Short-Course Chemotherapy Trial 21:effectiveness, toxicity, and acceptability. Ann Intern Med 1990;112:397-406 https://doi.org/10.7326/0003-4819-76-3-112-6-397
  27. Benator D, Bhattacharya M, Bozeman L, Burman W, Cantazaro A, Chaisson R, et al. Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial. Lancet 2002;360:528-34 https://doi.org/10.1016/S0140-6736(02)09742-8
  28. Chang KC, Leung CC, Yew WW, Ho SC, Tam CM. A nested case-control study on treatment-related risk factors for early relapse of tuberculosis. Am J Respir Crit Care Med 2004;170:1124-30 https://doi.org/10.1164/rccm.200407-905OC
  29. Bass JB Jr, Farer LS, Hopewell PC, O'Berien R, Jacobs RF, Ruben F, et al. Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med 1994;149:1359-74 https://doi.org/10.1164/ajrccm.149.5.8173779
  30. Tenover FC, Crawford JT, Huebner RE, Geiter LJ, Horsburgh CR Jr, Good RC. The resurgence of tuberculosis: is your laboratory ready? J Clin Microbiol 1993;31:767-70
  31. Chang CL, Park TS, Kim MN, Lee NY, Lee HJ, Suh JT. Survey on changes in mycobacterial testing practices in Korean laboratories. Korean J Clin Microbiol 2001;4:108-14
  32. Kim MN, Lee SH, Yang SE, Pai CH. Mycobacterial testing in hospital laboratories in Korea: results of a survey of 40 university or tertiary-care hospitals. Korean J Clin Pathol 1999;19:86-91
  33. Kim HJ, Hong YP, Kim SJ, Lew WJ, Lee EG. Ambulatory treatment of multidrug-resistant pulmonary tuberculosis patients at a chest clinic. Int J Tuberc Lung Dis 2001;5:1129-36
  34. Park SK, Lee WC, Lee DH, Mitnick CD, Han L, Seung KJ. Self-administered, standardized regimens for multidrug-resistant tuberculosis in South Korea. Int J Tuberc Lung Dis 2004;8:361-8
  35. Tahaoglu K, Torun T, Sevim T, Atac G, Kir A, Karasulu L, et al. The treatment of multidrug-resistant tuberculosis in Turkey. N Engl J Med 2001;345:170-4 https://doi.org/10.1056/NEJM200107193450303
  36. Mitnick C, Bayona J, Palacios E, Shin S, Furin J, Alcantara F, et al. Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. N Engl J Med 2003;348:119-28 https://doi.org/10.1056/NEJMoa022928
  37. Chan ED, Laurel V, Strand MJ, Chan JF, Huynh ML, Goble M, et al. Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis. Am J Respir Crit Care Med 2004;169:1103-9 https://doi.org/10.1164/rccm.200308-1159OC
  38. American Thoracic Society. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 1997;156:S1-25 https://doi.org/10.1164/ajrccm.156.2.atsstatement
  39. British Thoracic Society. Management of opportunist mycobacterial infections. Thorax 2000;55:210-8 https://doi.org/10.1136/thorax.55.3.210
  40. Hong YP, Kim SJ, Lee EG, LewWJ, Bai JY. Treatment of bacillary pulmonary tuberculosis at the chest clinics in the private sector in Korea, 1993. Int J Tuberc Lung Dis 1999;3:695-702
  41. Koh WJ, Kwon OJ, Kim CH, Ahn YM, Lim SY, Yun JW, et al. Clinical characteristics and treatment outcomes of patients with pulmonary tuberculosis at a private general hospital. Tuberc Respir Dis 2003;55:154-64 https://doi.org/10.4046/trd.2003.55.2.154
  42. Koh WJ, Kwon OJ. Treatment of tuberculosis patients in the private sector in Korea. Tuberc Respir Dis 2004;56:443-9 https://doi.org/10.4046/trd.2004.56.5.443